Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-934-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on absorption rate:
A dermal absorption study with EUF is technically not feasible.
Key value for chemical safety assessment
Additional information
- the synthesis of this technical product has to be transferred from a large-scale production process to a small-scale (very small) laboratory scale process. This implies that shifts within the product spectrum of this reaction are to be assumed.
- the supplier for radio-labelled compounds usually is delivering his product with a specific radioactivity (Bq/mol); this is not possible for a mixture like EUF.
- although some of the reactants can be obtained as radio-labelled a radio-labelled mixture is of restricted value for a metabolism study because proportion of labelled constituents it will remain unclear .
ADME and dermal absorption studies have not been conducted with EUF.
This type of studies usually requires that radio-labelled material is used to allow the sensitive detection and identification of the parent compound and its metabolites in the various matrices. The synthesis of a radiolabelled compound was not possible due the following reasons:
Discussion on absorption rate:
The relevant exposure path of EUF is the dermal route. In aqueous solutions (all biological systems) EUF hydrolyses to formaldehyde, ethylene glycol and urea.
Data on percutaneous absorption of EUF are lacking because of technical/methodological problems due to the reacting compounds and hydrolytic activity in aqueous solution.
Formaldehyde reacts at the site of entry and/or is eliminated rapidly as formic acid in the urine or as CO2 in the expired air or it enters the carbon pool in the body. The percutaneous absorption rate is 30-40%.
Data on the hydrolysis product ethylene glycol indicate that it is rapidly absorbed (dermal rate is 20 to 30%) and distributed in the body. It is metabolised and excreted via urine as ethylene glycol, glycolic acid, calcium oxalate, and glycine or hippurate and also exhaled as exhaled CO2. Urea is rapidly absorbed through human skin at a rate of about 10% and rapidly distributed as normal body constituent. Excretion is via urine in unchanged condition.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
